Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial. uri icon

authors

  • Saba, Nabil F
  • Rudra, Soumon
  • Remick, Jill
  • McDonald, Mark
  • Abousaud, Marin
  • Tan, Aik Choon
  • Fadlullah, Muhammad Zaki Hidayatullah
  • Chaudhary, Ritu
  • Muzaffar, Jameel
  • Kirtane, Kedar
  • Liu, Yuan
  • Steuer, Conor E
  • Chen, Georgia Z
  • Shin, Dong M
  • Teng, Yong
  • Chung, Christine H
  • Ekpenyong, Asari
  • McCook-Veal, Ashley
  • Magliocca, Kelly
  • Patel, Mihir
  • Nicole C. Schmitt, MD
  • Stokes, William
  • Bates, James E

publication date

  • July 2024